Is chemonucleolysis for painful lower back disc herniation returning? In the 1980s chymopapain achieved fairly wide spread use as a chemonucleolysis agent. Outcomes were highly technique and patient selection dependent. It eventually left the market. Now two large firms have inked a deal to bring a new chemonucleolysis approach to market. Will this one work?

Will a $95 Million Deal Bring Chemonucleolysis Back?

We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of a unique, essential and endlessly fascinating industry. What a great place to be!

Medicine

Science & Medicine

Health & Fitness

Doctors and patients report rushes for procedures as worries over ACA overhaul spike.

“Procedure Bum Rush” Before ACA Overhaul

According to their colleagues, these are the leading orthopedic hand surgeons in North America. Whether handling the wrist, elbow, or hand, these exemplary physicians have reached the pinnacle of their profession.

12 Leading North American Hand Surgeons

Renowned orthopedic surgeon Dr. Jamie Alexandra Dale is seeking justice and $31 million after she was attacked and left for dead by her ex-boyfriend and former NFL player Curtis Jordan. Her permanent injuries have left her unable to continue her surgery practice. Her story is not only heartbreaking but an indication of the economic toll this attack represented.

$31 Million Lawsuit: Orthopedic Surgeon Seeks Justice After Attack

Which companies will increase shoulder and foot/ankle market share in 2017. In mid-December we received a flashlight into the opaque future of those two dynamic extremity markets. The early Xmas gift came courtesy of top global medical technology analyst, Glenn Novarro. Here is what we learned.

10 Surprising 2017 Shoulder and Foot/Ankle Market Insights

It’s Donald Trump’s world in Washington. The Boss is driving agendas now and here’s the absolutely very latest. The ACA is first up. But there is also a spate of other year-end developments—primarily new digital healthcare initiatives—that should be noted.

Will a $95 Million Deal Bring Chemonucleolysis Back?

Download our free app to listen on your phone